Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel‐Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech, Matthieu Prot, Floriane Gallais, Pierre Gantner, Aurélie Velay, J. Le Guen, Najiby Kassis‐Chikhani, Dhiaeddine Edriss, Laurent Bélec, Aymeric Sève, Laura Courtellemont, Hélène Péré, Laurent Hocqueloux, Samira Fafi‐Kremer, Thiérry Prazuck, Hugo Mouquet, Timothée Bruel, Etienne Simon‐Lorière, F.A. Rey, Olivier Schwartz
Topics & Concepts
NeutralizationVirologyAntibodySpike ProteinMonoclonal antibodyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Lineage (genetic)Coronavirus disease 2019 (COVID-19)Immune escapeMedicineImmune systemImmunologyGeneticsGeneInfectious disease (medical specialty)PathologyDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing